Search all trials

Find therapies in clinical trials near you – page 20

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Interstitial lung disease

Not recruiting

Investigational

Study on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases

Investigational

Finland

Participants:65+ years
Substances:Bi 1015550

Contact Research Centre

Relapsing-remitting multiple sclerosis

Not recruiting

Investigational

Study on the Effects of Obexelimab for Patients with Relapsing Multiple Sclerosis

Investigational

Finland

Participants:18–64 years
Substances:Obexelimab

Contact Research Centre

EGFR gene mutation+1

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of BAY 2927088 Compared to Standard Treatment in Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations

Registered drugNo placebo

Finland

Participants:18–64 years · 65+ years
Substances:Bay 2927088

Contact Research Centre

Myasthenia gravis

Not recruiting

Registered drug

Study on Efgartigimod IV for Adults with Seronegative Generalized Myasthenia Gravis

Registered drug

Finland

Participants:18–64 years · 65+ years
Substances:Efgartigimod Alfa

Contact Research Centre

Gastrointestinal stromal tumour

Not recruiting

Registered drugNo placebo

Study on the Effect of Extending Imatinib Treatment from Three to Five Years for Patients with High-Risk Gastrointestinal Stromal Tumor (GIST)

Registered drugNo placebo

Finland

Participants:18–64 years · 65+ years
Substances:Imatinib

Contact Research Centre

Ovarian cancer

Not recruiting

Registered drugNo placebo

Study of Olaparib, Durvalumab and UV1 combination as maintenance treatment for patients with recurrent ovarian cancer who do not have BRCA mutations

Registered drugNo placebo

Finland

Participants:18–64 years · 65+ years
Substances:Alrefimotide

Contact Research Centre

Malignant melanoma stage IV+1

Not recruiting

Registered drugNo placebo

Study of Nivolumab and Relatlimab for Patients with Stage III-IV Melanoma After Surgery

Registered drugNo placebo

Finland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Prostate cancer recurrent

Not recruiting

Registered drugNo placebo

Study on Adding Apalutamide to Radiotherapy and LHRH Agonist for High-Risk Patients with Hormone-Sensitive Prostate Cancer

Registered drugNo placebo

Finland

Participants:18–64 years · 65+ years
Substances:Apalutamide

Contact Research Centre

Endometrial cancer

Not recruiting

Registered drugNo placebo

Study on MK-2870 for Patients with Endometrial Cancer After Platinum and Immunotherapy Treatment

Registered drugNo placebo

Finland

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid

Contact Research Centre

Psoriatic arthropathy

Not recruiting

Investigational

Study of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy

Investigational

Finland

Participants:18–64 years · 65+ years
Substances:Risankizumab

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

Registered drug

Study on the Effectiveness and Safety of GSK4527226 in Patients with Early Alzheimer's Disease

Registered drug

Finland

Participants:18–64 years · 65+ years
Substances:Florbetaben (18F)

Contact Research Centre

Pneumococcal infection

Not recruiting

Registered drugNo placebo

Study on the Safety and Immune Response of V116 Vaccine in Children and Adolescents at Higher Risk for Pneumococcal Disease

Registered drugNo placebo

Finland

Participants:0–17 years
Substances:Abc-15A-116

Contact Research Centre

Find therapies in clinical trials near you – page 20

297 trials match your criteria

Interstitial lung disease

Study on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases

Relapsing-remitting multiple sclerosis

Study on the Effects of Obexelimab for Patients with Relapsing Multiple Sclerosis

EGFR gene mutation+1

Study on the Effectiveness and Safety of BAY 2927088 Compared to Standard Treatment in Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations

Myasthenia gravis

Study on Efgartigimod IV for Adults with Seronegative Generalized Myasthenia Gravis

Gastrointestinal stromal tumour

Study on the Effect of Extending Imatinib Treatment from Three to Five Years for Patients with High-Risk Gastrointestinal Stromal Tumor (GIST)

Ovarian cancer

Study of Olaparib, Durvalumab and UV1 combination as maintenance treatment for patients with recurrent ovarian cancer who do not have BRCA mutations

Malignant melanoma stage IV+1

Study of Nivolumab and Relatlimab for Patients with Stage III-IV Melanoma After Surgery

Prostate cancer recurrent

Study on Adding Apalutamide to Radiotherapy and LHRH Agonist for High-Risk Patients with Hormone-Sensitive Prostate Cancer

Endometrial cancer

Study on MK-2870 for Patients with Endometrial Cancer After Platinum and Immunotherapy Treatment

Psoriatic arthropathy

Study of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy

Dementia Alzheimer's type

Study on the Effectiveness and Safety of GSK4527226 in Patients with Early Alzheimer's Disease

Pneumococcal infection

Study on the Safety and Immune Response of V116 Vaccine in Children and Adolescents at Higher Risk for Pneumococcal Disease

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.